IS INCREASED HCV CASE-FINDING COMBINED WITH CURRENT OR 8–12 WEEK DAA THERAPY COST-EFFECTIVE IN UK PRISONS? A PREVENTION BENEFIT ANALYSIS

BACKGROUND: Prisoners have a high prevalence of Hepatitis C virus (HCV), but case-finding may not have been cost-effective because treatment often exceeded average prison stay combined with a lack of continuity-of-care. We assess the cost-effectiveness of increased HCV case-finding and treatment in...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hepatology
Auteurs principaux: Martin, Natasha K, Vickerman, Peter, Brew, Iain F, Williamson, Joan, Miners, Alec, Irving, William L, Saksena, Sushma, Hutchinson, Sharon J, Mandal, Sema, O’Moore, Eamonn, Hickman, Matthew
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4920048/
https://ncbi.nlm.nih.gov/pubmed/26864802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28497
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires